CATX - Perspective Therapeutics, Inc.

QQQ $ 454.01 $ 0.54 (0.12 %)

DIA $ 400.38 $ 1.10 (0.28 %)

SPY $ 530.73 $ 0.80 (0.15 %)

TLT $ 92.12 $ -0.27 (-0.29 %)

GLD $ 220.44 $ -0.45 (-0.2 %)

Previous Close

$ 1.57

Open

$ 1.58

Bid

$ 1.49 x 300

Ask

$ 1.50 x 2,000

Day's Range

$ 1.46 - $ 1.60

52 Week Range

$ 0.21 - $ 1.91

Volume

18,110,425

Average Volume

Market Cap

777.31M

Beta (5Y Monthly)

$ 0.69

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-15-2024	03-31-2024	10-Q
2	03-28-2024	12-31-2023	10-K
3	11-14-2023	09-30-2023	10-Q
4	08-11-2023	06-30-2023	10-Q
5	05-15-2023	03-31-2023	10-Q
6	11-14-2022	09-30-2022	10-Q
7	09-28-2022	06-30-2022	10-K
8	05-12-2022	03-31-2022	10-Q
9	02-09-2022	12-31-2021	10-Q
10	11-10-2021	09-30-2021	10-Q
11	09-27-2021	06-30-2021	10-K
12	05-14-2021	03-31-2021	10-Q
13	02-09-2021	12-31-2020	10-Q
14	11-13-2020	09-30-2020	10-Q
15	09-25-2020	06-30-2020	10-K
16	05-13-2020	03-31-2020	10-Q
17	02-12-2020	12-31-2019	10-Q
18	11-13-2019	09-30-2019	10-Q
19	09-27-2019	06-30-2019	10-K
20	05-10-2019	03-31-2019	10-Q
21	02-13-2019	12-31-2018	10-Q
22	11-09-2018	09-30-2018	10-Q
23	09-26-2018	06-30-2018	10-K
24	05-04-2018	03-31-2018	10-Q
25	02-09-2018	12-31-2017	10-Q
26	11-14-2017	09-30-2017	10-Q
27	09-28-2017	06-30-2017	10-K
28	05-10-2017	03-31-2017	10-Q
29	02-09-2017	12-31-2016	10-Q
30	11-09-2016	09-30-2016	10-Q
31	09-09-2016	06-30-2016	10-K
32	05-10-2016	03-31-2016	10-Q
33	02-09-2016	12-31-2015	10-Q
34	11-09-2015	09-30-2015	10-Q
35	09-14-2015	06-30-2015	10-K
36	05-15-2015	03-31-2015	10-Q
37	02-17-2015	12-31-2014	10-Q
38	11-14-2014	09-30-2014	10-Q
39	09-29-2014	06-30-2014	10-K
40	05-15-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Jones Trading Maintains Buy on Perspective...
05/16/2024 16:28:06

Jones Trading analyst Justin Walsh maintains Perspective Therapeutics (AMEX:CATX) with a Buy and raises the price target fro...

Perspective Therapeutics Q1 2024 GAAP EPS ...
05/15/2024 11:04:08

RBC Capital Initiates Coverage On Perspect...
05/14/2024 12:03:13

RBC Capital analyst Gregory Renza initiates coverage on Perspective Therapeutics (AMEX:CATX) with a Outperform rating and an...

Cantor Fitzgerald Initiates Coverage On Pe...
05/09/2024 10:22:12

Cantor Fitzgerald analyst Louis Chen initiates coverage on Perspective Therapeutics (AMEX:CATX) with a Overweight rating.

FDA Selects Perspective Therapeutics To Pa...
04/30/2024 11:20:47

B. Riley Securities Maintains Buy on Persp...
04/09/2024 17:47:01

B. Riley Securities analyst Yuan Zhi maintains Perspective Therapeutics (AMEX:CATX) with a Buy and raises the price target f...

Oppenheimer Reiterates Outperform on Persp...
04/01/2024 13:27:02

Oppenheimer analyst Jeff Jones reiterates Perspective Therapeutics (AMEX:CATX) with a Outperform and raises the price target...

stocks-pause-as-traders-reassess-interest-rate-path-gold-makes-new-highs-bitcoin-rebounds-whats-driving-markets-thursday

Stocks Pause As Traders Reassess Interest ...
03/28/2024 17:49:57

In the final session of the short trading week leading up to Easter festivities, U.S. equity indices held steady, reflecting so...

Perspective Therapeutics FY2023 EPS $(0.14...
03/28/2024 11:35:34

Perspective Therapeutics (AMEX:CATX) reported quarterly losses of $(0.14) per share. This is a 133.33 percent decrease over los...

Oppenheimer Reiterates Outperform on Persp...
03/19/2024 13:02:16

Oppenheimer analyst Jeff Jones reiterates Perspective Therapeutics (AMEX:CATX) with a Outperform and maintains $1.2 price ta...

Perspective Therapeutics Announces Collabo...
03/18/2024 12:06:16

Perspective Therapeutics Acquires CGMP-Com...
03/05/2024 13:12:16

Perspective Therapeutics, Inc. ("Perspective" or "the Company") (NYSE:CATX), a radiopharmaceutical company that...

Perspective Therapeutics Shares Resume Trade
03/04/2024 15:00:34

Perspective Therapeutics Announces $87.4M ...
03/04/2024 14:46:14

Perspective Therapeutics, Inc. ("Perspective" or "the Company") (NYSE:CATX), a radiopharmaceutical company that...

Perspective Therapeutics Shares Halted, Ne...
03/04/2024 14:34:27

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
02/15/2024 21:31:05

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
02/09/2024 21:31:09

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
02/07/2024 17:31:16

expensify-and-3-other-stocks-under-3-insiders-are-buying

Expensify And 3 Other Stocks Under $3 Insi...
02/02/2024 12:09:11

The Dow Jones index closed higher by more than 350 points on Thursday. When insiders purchase or sell shares, it indicates thei...

Perspective Therapeutics Signs License Agr...
02/01/2024 13:15:18

Signs a World-Wide Exclusive License with Stony Brook University for a Novel Platform that can Enhance Radionuclide Targeting R...